Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04873817 · ClinicalTrials.gov registry record
Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 184
- Enrollment target
NCT04873817 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 184 participants.
The verdict
NCT04873817 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 184 participants
- Enrollment target
Study Summary
ROSTRA is an international, prospective, non-randomized, single-arm, multi-center, and post-market study to collect real-world safety and effectiveness data on Abbott's IonicRF™Generator and compatible RFA accessories. This post-market study is intended to satisfy EU MDR requirements.
Interventions
- DEVICE IonicRF Generator and compatible accessories
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2023-03-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04873817
The ClinicalTrials.gov registry entry for NCT04873817 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IonicRF Generator and compatible accessories is the first listed.
NCT04873817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04873817 about?
NCT04873817 is a clinical study titled "Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation". ROSTRA is an international, prospective, non-randomized, single-arm, multi-center, and post-market study to collect real-world safety and effectiveness data on Abbott's IonicRF™Generator and compatible RFA accessories. This post-market study is intended to satisfy EU MDR requirements.
What is the current status of trial NCT04873817?
This trial is currently completed. The enrollment target is 184 participants. The study started on 2021-06-29. Estimated completion is 2023-03-08.
What interventions are being tested in trial NCT04873817?
The interventions under investigation include: IonicRF Generator and compatible accessories (DEVICE).
Who is sponsoring clinical trial NCT04873817?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.